From leeches to personalized medicine: evolving concepts in the management of polycythemia vera

von Vannucchi, Alessandro M.
Veröffentlicht in Haematologica (2017)

Recent advances in diagnosis and treatment of chronic myeloproliferative neoplasms

von Guglielmelli, Paola, Vannucchi, Alessandro M
Veröffentlicht 2010

Epigenetics and mutations in chronic myeloproliferative neoplasms

von Vannucchi, Alessandro M., Biamonte, Flavia
Veröffentlicht 2011

Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for clinicians

von Harrison, Claire, Vannucchi, Alessandro M.
Veröffentlicht 2012

What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?

von Vannucchi, Alessandro M., Guglielmelli, Paola
Veröffentlicht in Hematology Am Soc Hematol Educ Program (2017)

Chronic Myeloproliferative Neoplasms: a Collaborative Approach

von Pieri, Lisa, Guglielmelli, Paola, Vannucchi, Alessandro M.
Veröffentlicht 2010

JAK2 Allele Burden in the Myeloproliferative Neoplasms: Effects on Phenotype, Prognosis and Change with Treatment

von Vannucchi, Alessandro M., Pieri, Lisa, Guglielmelli, Paola
Veröffentlicht 2011

Essential thrombocythemia treatment algorithm 2018

von Tefferi, Ayalew, Vannucchi, Alessandro M., Barbui, Tiziano
Veröffentlicht in Blood Cancer J (2018)

Polycythemia vera treatment algorithm 2018

von Tefferi, Ayalew, Vannucchi, Alessandro M., Barbui, Tiziano
Veröffentlicht in Blood Cancer J (2018)

Prefibrotic myelofibrosis: treatment algorithm 2018

von Finazzi, Guido, Vannucchi, Alessandro M., Barbui, Tiziano
Veröffentlicht in Blood Cancer J (2018)

Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data

von Loscocco, Giuseppe G, Guglielmelli, Paola, Vannucchi, Alessandro M
Veröffentlicht in Onco Targets Ther (2020)

Myelofibrosis Treatment Algorithm 2018

von Tefferi, Ayalew, Guglielmelli, Paola, Pardanani, Animesh, Vannucchi, Alessandro M.
Veröffentlicht in Blood Cancer J (2018)

Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms

von Barbui, Tiziano, Finazzi, Guido, Vannucchi, Alessandro M., De Stefano, Valerio
Veröffentlicht in Blood Cancer J (2018)

Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives

von Vannucchi, Alessandro M, Guglielmelli, Paola, Rambaldi, Alessandro, Bogani, Costanza, Barbui, Tiziano
Veröffentlicht 2009

The new WHO classification for essential thrombocythemia calls for revision of available evidences

von Barbui, Tiziano, Thiele, Jürgen, Ferrari, Alberto, Vannucchi, Alessandro M., Tefferi, Ayalew
Veröffentlicht in Blood Cancer J (2020)

JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia m...

von Guglielmelli, Paola, Barosi, Giovanni, Pieri, Lisa, Antonioli, Elisabetta, Bosi, Alberto, Vannucchi, Alessandro M.
Veröffentlicht 2009

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cy...

von Barbui, Tiziano, Carobbio, Alessandra, Ghirardi, Arianna, Masciulli, Arianna, Rambaldi, Alessandro, Vannucchi, Alessandro M.
Veröffentlicht in Haematologica (2017)

Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera

von Barbui, Tiziano, De Stefano, Valerio, Ghirardi, Arianna, Masciulli, Arianna, Finazzi, Guido, Vannucchi, Alessandro M.
Veröffentlicht in Blood Cancer J (2018)

A Sensitive Detection Method for MPLW515L or MPLW515K Mutation in Chronic Myeloproliferative Disorders with Locked Nucleic Acid-Modified Probes and Real-Time Polymerase Chain React...

von Pancrazzi, Alessandro, Guglielmelli, Paola, Ponziani, Vanessa, Bergamaschi, Gaetano, Bosi, Alberto, Barosi, Giovanni, Vannucchi, Alessandro M.
Veröffentlicht 2008

Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia

von Gianfaldoni, Giacomo, Mannelli, Francesco, Ponziani, Vanessa, Longo, Giovanni, Bencini, Sara, Bosi, Alberto, Vannucchi, Alessandro M.
Veröffentlicht 2010